Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-022320
Filing Date
2020-11-03
Accepted
2020-11-03 10:01:08
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20200930_10q.htm   iXBRL 10-Q 1317706
2 EXHIBIT 31.1 ex_197202.htm EX-31.1 15289
3 EXHIBIT 31.2 ex_197203.htm EX-31.2 15365
4 EXHIBIT 32 ex_197204.htm EX-32 6722
  Complete submission text file 0001437749-20-022320.txt   5134175

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA oxfd-20200930.xsd EX-101.SCH 48758
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxfd-20200930_cal.xml EX-101.CAL 47169
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxfd-20200930_def.xml EX-101.DEF 314145
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxfd-20200930_lab.xml EX-101.LAB 266811
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxfd-20200930_pre.xml EX-101.PRE 340741
10 EXTRACTED XBRL INSTANCE DOCUMENT oxfd20200930_10q_htm.xml XML 714581
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 201282165
SIC: 2835 In Vitro & In Vivo Diagnostic Substances